Fernandez Calero Miguel Angel

SEC source: 0001127602-23-012777 · form4.xml · nonDerivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 595,740

F2 · shares: Represents shares awarded to reporting person in connection with the vesting of performance-based PSUs initially awarded on April 6, 2020. 48,700 shares were surrendered to cover the resulting tax liability.

SEC source: 0001127602-23-012777 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 444,440

F1 · shares: Shares were withheld by the Issuer upon the vesting of 1/3 of the reporting person's April 6, 2020 restricted stock units award to cover the resulting tax liability. On April 6, 2020, the reporting person was granted 425,532 restricted stock units with a vesting schedule of 3 equal annual installments beginning on April 6, 2021, the first anniversary of the grant.

SEC source: 0001127602-23-009899 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 478,980

F1 · shares: Shares were withheld by the Issuer upon the vesting of 1/3 of the reporting person's March 12, 2021 restricted stock units award to cover the resulting tax liability. On March 12, 2021, the reporting person was granted 30,025 restricted stock units with a vesting schedule of 3 equal annual installments beginning on March 12, 2022, the first anniversary of the grant.

SEC source: 0001127602-23-007547 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 481,417

F1 · kind: Shares were withheld by the Issuer upon the vesting of 1/3 of the reporting person's February 25, 2022 restricted stock units award to cover the resulting tax liability. On February 25, 2022, the reporting person was granted 55,013 restricted stock units with a vesting schedule of 3 equal annual installments beginning on February 25, 2023, the first anniversary of the grant.

SEC source: 0001127602-22-024989 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 485,965

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.20 to $4.24, inclusive. The reporting person undertakes to provide to Tupperware Brands Corporation, any security holder of Tupperware Brands Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001127602-22-017471 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 461,965

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.97 to $6.01, inclusive. The reporting person undertakes to provide to Tupperware Brands Corporation, any security holder of Tupperware Brands Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

SEC source: 0001127602-22-011778 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 426,965

F1 · price: Shares were withheld by the Issuer upon the 1/3 vesting of the reporting person's April 6, 2020 Restricted Stock Units award to cover the resulting tax liability. On April 6, 2020, the reporting person was granted 425,532 Restricted Stock Units with a vesting schedule of three equal annual installments beginning on April 6, 2021, the first anniversary of the grant.

SEC source: 0001127602-22-009253 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 482,329

F1 · price: Shares were withheld by the Issuer upon the vesting of 1/3 of the reporting person's March 12, 2021 restricted stock units award to cover the resulting tax liability. On March 12, 2021, the reporting person was granted 30,025 restricted stock units with a vesting schedule of 3 equal annual installments beginning on March 12, 2022, the first anniversary of the grant.

SEC source: 0001127602-22-008015 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 484,754

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $19.68 to $19.74, inclusive. The reporting person undertakes to provide to Tupperware Brands Corporation, any security holder of Tupperware Brands Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001127602-22-007199 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 474,754

F1 · date: Restricted Stock Unit award vests in 3 equal annual installments beginning on February 25, 2023.

SEC source: 0001127602-21-013398 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 419,741

F1 · kind: Shares were withheld by the Issuer upon the 1/3 vesting of the reporting person's April 6, 2020 Restricted Stock Units award to cover the resulting tax liability. On April 6, 2020, the reporting person was granted 425,532 Restricted Stock Units with a vesting schedule of three equal annual installments beginning on April 6, 2021, the first anniversary of the grant.

SEC source: 0001127602-21-010503 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 445,532

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.53 to $25.18, inclusive. The reporting person undertakes to provide to Tupperware Brands Corporation, any security holder of Tupperware Brands Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.

SEC source: 0001127602-21-010755 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 475,557

F1 · date: Restricted Stock Unit award vests in 3 equal annual installments beginning on March 12, 2022.

SEC source: 0001127602-20-013459 · form4.xml · derivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2025-04-06

F2 · derivative.exercise_price: Each performance unit represents a contingent right to receive one share of the Issuer's common stock, upon satisfaction of vesting conditions based on the closing price of the Issuer's common stock as described in the applicable award agreement, filed with the Securities and Exchange Commission as Exhibit 10.1 to Form S-8 on March 12, 2020.

F2 · derivative.exercise_date: Each performance unit represents a contingent right to receive one share of the Issuer's common stock, upon satisfaction of vesting conditions based on the closing price of the Issuer's common stock as described in the applicable award agreement, filed with the Securities and Exchange Commission as Exhibit 10.1 to Form S-8 on March 12, 2020.

SEC source: 0001127602-20-013459 · form4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 425,532

F1 · shares: Restricted Stock Unit award vests in three equal annual installments beginning on April 6, 2021.

SEC source: 0001209191-20-002355 · doc4.xml · derivative · entry 3

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 915,589 shares

Expires not disclosed

F2 · derivative.exercise_price: Each award of Avon Stock Options outstanding at the effective time of the Merger was canceled in exchange for the right to receive an amount in cash equal to the aggregate spread value of such award. 307,753 options had an exercise price of $3.44, 307,753 options had an exercise price of $3.49 and 300,083 options had an exercise price of $3.30. The closing price on the date of the Merger was $5.60.

F2 · price: Each award of Avon Stock Options outstanding at the effective time of the Merger was canceled in exchange for the right to receive an amount in cash equal to the aggregate spread value of such award. 307,753 options had an exercise price of $3.44, 307,753 options had an exercise price of $3.49 and 300,083 options had an exercise price of $3.30. The closing price on the date of the Merger was $5.60.

F2 · derivative.exercise_date: Each award of Avon Stock Options outstanding at the effective time of the Merger was canceled in exchange for the right to receive an amount in cash equal to the aggregate spread value of such award. 307,753 options had an exercise price of $3.44, 307,753 options had an exercise price of $3.49 and 300,083 options had an exercise price of $3.30. The closing price on the date of the Merger was $5.60.

F2 · derivative.expiration_date: Each award of Avon Stock Options outstanding at the effective time of the Merger was canceled in exchange for the right to receive an amount in cash equal to the aggregate spread value of such award. 307,753 options had an exercise price of $3.44, 307,753 options had an exercise price of $3.49 and 300,083 options had an exercise price of $3.30. The closing price on the date of the Merger was $5.60.

SEC source: 0001209191-20-002355 · doc4.xml · derivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 683,407 shares

Expires not disclosed

F1 · derivative.exercise_price: In conjunction with Avon Products, Inc.'s ("Avon") merger with Natura Cosmeticos S.A. (the "Merger") that was completed on 01/03/2020 each share of Avon stock converted into the right to receive shares of Natura & Co. Holding.

F1 · price: In conjunction with Avon Products, Inc.'s ("Avon") merger with Natura Cosmeticos S.A. (the "Merger") that was completed on 01/03/2020 each share of Avon stock converted into the right to receive shares of Natura & Co. Holding.

F1 · derivative.exercise_date: In conjunction with Avon Products, Inc.'s ("Avon") merger with Natura Cosmeticos S.A. (the "Merger") that was completed on 01/03/2020 each share of Avon stock converted into the right to receive shares of Natura & Co. Holding.

F1 · derivative.expiration_date: In conjunction with Avon Products, Inc.'s ("Avon") merger with Natura Cosmeticos S.A. (the "Merger") that was completed on 01/03/2020 each share of Avon stock converted into the right to receive shares of Natura & Co. Holding.

SEC source: 0001209191-20-002355 · doc4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: In conjunction with Avon Products, Inc.'s ("Avon") merger with Natura Cosmeticos S.A. (the "Merger") that was completed on 01/03/2020 each share of Avon stock converted into the right to receive shares of Natura & Co. Holding.

SEC source: 0001209191-20-000479 · doc4.xml · derivative · entry 5

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 261,321

Underlying: Common Stock · 120,246 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units and restricted stock convert into common stock on a 1-for-1 basis.

F3 · shares: Represents shares withheld for tax purposes.

F4 · price: Shares calculated for withholding at the closing price on the date of the transaction, or $5.70.

F5 · price: In anticipation of the Upcoming Merger and with approval of the Compensation and Management Development Committee of the Board of Directors, previously granted performance-based restricted stock units (PSUs) were converted into restricted stock on 12/30/19. The restricted stock granted in place of the PSUs retain the PSUs' original vesting dates and vest as follows: 68,064 on 8/21/20; 86,588 on 3/14/21; and 106,669 on 3/13/22.

F5 · derivative.exercise_date: In anticipation of the Upcoming Merger and with approval of the Compensation and Management Development Committee of the Board of Directors, previously granted performance-based restricted stock units (PSUs) were converted into restricted stock on 12/30/19. The restricted stock granted in place of the PSUs retain the PSUs' original vesting dates and vest as follows: 68,064 on 8/21/20; 86,588 on 3/14/21; and 106,669 on 3/13/22.

F5 · derivative.expiration_date: In anticipation of the Upcoming Merger and with approval of the Compensation and Management Development Committee of the Board of Directors, previously granted performance-based restricted stock units (PSUs) were converted into restricted stock on 12/30/19. The restricted stock granted in place of the PSUs retain the PSUs' original vesting dates and vest as follows: 68,064 on 8/21/20; 86,588 on 3/14/21; and 106,669 on 3/13/22.

SEC source: 0001209191-20-000479 · doc4.xml · derivative · entry 4

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 381,567

Underlying: Common Stock · 381,567 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units and restricted stock convert into common stock on a 1-for-1 basis.

F5 · shares: In anticipation of the Upcoming Merger and with approval of the Compensation and Management Development Committee of the Board of Directors, previously granted performance-based restricted stock units (PSUs) were converted into restricted stock on 12/30/19. The restricted stock granted in place of the PSUs retain the PSUs' original vesting dates and vest as follows: 68,064 on 8/21/20; 86,588 on 3/14/21; and 106,669 on 3/13/22.

F1 · price: Restricted stock units and restricted stock convert into common stock on a 1-for-1 basis.

F5 · price: In anticipation of the Upcoming Merger and with approval of the Compensation and Management Development Committee of the Board of Directors, previously granted performance-based restricted stock units (PSUs) were converted into restricted stock on 12/30/19. The restricted stock granted in place of the PSUs retain the PSUs' original vesting dates and vest as follows: 68,064 on 8/21/20; 86,588 on 3/14/21; and 106,669 on 3/13/22.

F5 · derivative.exercise_date: In anticipation of the Upcoming Merger and with approval of the Compensation and Management Development Committee of the Board of Directors, previously granted performance-based restricted stock units (PSUs) were converted into restricted stock on 12/30/19. The restricted stock granted in place of the PSUs retain the PSUs' original vesting dates and vest as follows: 68,064 on 8/21/20; 86,588 on 3/14/21; and 106,669 on 3/13/22.

F5 · derivative.expiration_date: In anticipation of the Upcoming Merger and with approval of the Compensation and Management Development Committee of the Board of Directors, previously granted performance-based restricted stock units (PSUs) were converted into restricted stock on 12/30/19. The restricted stock granted in place of the PSUs retain the PSUs' original vesting dates and vest as follows: 68,064 on 8/21/20; 86,588 on 3/14/21; and 106,669 on 3/13/22.

SEC source: 0001209191-20-000479 · doc4.xml · derivative · entry 3

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 422,086

Underlying: Common Stock · 190,351 shares

Expires not disclosed

F1 · derivative.exercise_price: Restricted stock units and restricted stock convert into common stock on a 1-for-1 basis.

F3 · shares: Represents shares withheld for tax purposes.

F2 · price: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

F4 · price: Shares calculated for withholding at the closing price on the date of the transaction, or $5.70.

F2 · derivative.exercise_date: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

F2 · derivative.expiration_date: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

SEC source: 0001209191-20-000479 · doc4.xml · derivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 612,437

Underlying: Common Stock · 612,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units and restricted stock convert into common stock on a 1-for-1 basis.

F2 · shares: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

F1 · price: Restricted stock units and restricted stock convert into common stock on a 1-for-1 basis.

F2 · price: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

F2 · derivative.exercise_date: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

F2 · derivative.expiration_date: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

SEC source: 0001209191-20-000479 · doc4.xml · derivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 612,437 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units and restricted stock convert into common stock on a 1-for-1 basis.

F1 · price: Restricted stock units and restricted stock convert into common stock on a 1-for-1 basis.

F2 · price: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

F2 · derivative.exercise_date: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

F2 · derivative.expiration_date: Restricted Stock Units were granted on 8/21/2017, 3/14/2018 and 3/13/2019 and were scheduled to vest into common stock on 8/21/20, 3/14/2021 and 3/13/2022. In anticipation of Avon Products, Inc.'s upcoming merger with Natura Cosmeticos S.A. (the "Upcoming Merger") and with approval of the Compensation and Management Development Committee of the Board of Directors, the Units were converted into restricted stock on 12/30/19 and retain the Units' original vesting date and will vest as follows: 81,028 on 8/21/20; 84,336 on 3/14/21; and 256,721 on 3/13/22.

SEC source: 0001209191-19-019662 · doc4.xml · derivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,753

Underlying: Common Stock · 307,753 shares

Expires 2029-03-13

F4 · derivative.exercise_price: The exercise price of this premium-priced stock option is equal to 125% of the closing price of Avon's common stock on the date of grant.

F5 · derivative.exercise_date: This option vests in three equal annual installments beginning on 03/13/2020.

SEC source: 0001209191-19-019662 · doc4.xml · derivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,303

Underlying: Common Stock · 369,303 shares

Expires not disclosed

F1 · security: The reporting person has irrevocably elected to satisfy all withholding tax due upon the delivery of shares by authorizing Avon Products, Inc. to withhold a sufficient amount of shares to satisfy such tax obligation.

F2 · derivative.exercise_price: Units correspond 1-for-1 with common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units are scheduled to vest on 03/13/2022.

F3 · derivative.expiration_date: 100% of the restricted stock units are scheduled to vest on 03/13/2022.

SEC source: 0001209191-18-030754 · doc4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Global President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

SEC source: 0001209191-18-020385 · doc4.xml · derivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 307,753

Underlying: Common Stock · 307,753 shares

Expires 2028-03-14

F4 · derivative.exercise_price: The exercise price of this premium-priced stock option is equal to 125% of the closing price of Avon's common stock on the date of grant.

F5 · derivative.exercise_date: This option vests in three equal annual installments beginning on 03/14/2019.

SEC source: 0001209191-18-020385 · doc4.xml · derivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,101

Underlying: Common Stock · 123,101 shares

Expires not disclosed

F1 · security: The reporting person has irrevocably elected to satisfy all withholding tax due upon the delivery of shares by authorizing Avon Products, Inc. to withhold a sufficient amount of shares to satisfy such tax obligation.

F2 · derivative.exercise_price: Units correspond 1-for-1 with common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units are scheduled to vest on 03/14/2021.

F3 · derivative.expiration_date: 100% of the restricted stock units are scheduled to vest on 03/14/2021.

SEC source: 0001209191-17-049848 · doc4a.xml · derivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,083

Underlying: Common Stock · 300,083 shares

Expires 2027-08-21

F5 · derivative.exercise_price: The exercise price of this premium-priced stock option is equal to 125% of the closing price of Avon's common stock on the date of grant.

F3 · date: The original Form 4 was filed prematurely as the Reporting Person's commencement date was delayed for administrative reasons beyond his control. The grants reported in this form were, therefore, delayed and now reflect the actual grant date.

F6 · derivative.exercise_date: This option vests in three equal annual installments beginning on 08/21/2018.

SEC source: 0001209191-17-049848 · doc4a.xml · derivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,033

Underlying: Common Stock · 120,033 shares

Expires not disclosed

F1 · security: The reporting person has irrevocably elected to satisfy all withholding tax due upon the delivery of shares by authorizing Avon Products, Inc. to withhold a sufficient amount of shares to satisfy such tax obligation.

F2 · derivative.exercise_price: Units correspond 1-for-1 with common stock.

F3 · date: The original Form 4 was filed prematurely as the Reporting Person's commencement date was delayed for administrative reasons beyond his control. The grants reported in this form were, therefore, delayed and now reflect the actual grant date.

F4 · derivative.exercise_date: 100% of the restricted stock units are scheduled to vest on 8/21/2020.

F4 · derivative.expiration_date: 100% of the restricted stock units are scheduled to vest on 8/21/2020.

SEC source: 0001209191-17-049017 · doc4.xml · derivative · entry 2

Fernandez Calero Miguel Angel · CIK 0001472194 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,083

Underlying: Common Stock · 300,083 shares

Expires 2027-08-14

F4 · derivative.exercise_price: The exercise price of this premium-priced stock option is equal to 125% of the closing price of Avon's common stock on the date of grant.

F5 · derivative.exercise_date: This option vests in three equal annual installments beginning on 08/14/2018.

SEC source: 0001209191-17-049017 · doc4.xml · derivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,033

Underlying: Common Stock · 120,033 shares

Expires not disclosed

F1 · security: The reporting person has irrevocably elected to satisfy all withholding tax due upon the delivery of shares by authorizing Avon Products, Inc. to withhold a sufficient amount of shares to satisfy such tax obligation.

F2 · derivative.exercise_price: Units correspond 1-for-1 with common stock.

F3 · derivative.exercise_date: 100% of the restricted stock units are scheduled to vest on 8/14/2020.

F3 · derivative.expiration_date: 100% of the restricted stock units are scheduled to vest on 8/14/2020.

SEC source: 0001209191-17-032494 · doc4.xml · nonDerivative · entry 1

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: This transaction was executed in multiple trades at prices ranging from $71.71 to $72.28. The price reported above reflects the weighted average purchase price of $72.02. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2 · balance_after: The total number of shares has been adjusted to reduce the share balance by 25 shares inadvertently included in prior reports.

SEC source: 0001209191-17-031681 · doc4.xml · derivative · entry 20

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,467

Underlying: Common Stock · 4,367 shares

Expires 2026-05-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Consists of 21,834 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on May 9, 2017, 20% will vest on May 9, 2018 and the remaining 60% will vest on May 9, 2019.

F7 · balance_after: Consists of 21,834 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on May 9, 2017, 20% will vest on May 9, 2018 and the remaining 60% will vest on May 9, 2019.

SEC source: 0001209191-17-031681 · doc4.xml · derivative · entry 19

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,811

Underlying: Common Stock · 21,206 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Consists of 53,017 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on March 2, 2016, 20% vested on March 2, 2017, and the remaining 60% will vest on March 2, 2018.

F6 · balance_after: Consists of 53,017 stock appreciation rights granted under the Herbalife Ltd. 2014 Stock Incentive Plan, of which 20% vested on March 2, 2016, 20% vested on March 2, 2017, and the remaining 60% will vest on March 2, 2018.

SEC source: 0001209191-17-031681 · doc4.xml · derivative · entry 18

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,019 shares

Expires 2024-04-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031681 · doc4.xml · derivative · entry 17

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 19,672 shares

Expires 2022-05-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031681 · doc4.xml · derivative · entry 16

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,750 shares

Expires 2021-05-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 15

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,426

F5 · kind: The reporting person received 400 shares of common stock upon the net exercise of the 4,367 SARS. The reporting person forfeited 3,750 shares of common stock underlying the SARS in payment of the exercise price and 217 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 14

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,643

F5 · kind: The reporting person received 400 shares of common stock upon the net exercise of the 4,367 SARS. The reporting person forfeited 3,750 shares of common stock underlying the SARS in payment of the exercise price and 217 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 13

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 12

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,026

F4 · kind: The reporting person received 8,020 shares of common stock upon the net exercise of the 21,206 SARS. The reporting person forfeited 8,866 shares of common stock underlying the SARS in payment of the exercise price and 4,320 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 11

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,346

F4 · kind: The reporting person received 8,020 shares of common stock upon the net exercise of the 21,206 SARS. The reporting person forfeited 8,866 shares of common stock underlying the SARS in payment of the exercise price and 4,320 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 10

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,212

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 9

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,006

F3 · kind: The reporting person received 2,863 shares of common stock upon the net exercise of the 25,019 SARS. The reporting person forfeited 20,612 shares of common stock underlying the SARS in payment of the exercise price and 1,544 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 8

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,550

F3 · kind: The reporting person received 2,863 shares of common stock upon the net exercise of the 25,019 SARS. The reporting person forfeited 20,612 shares of common stock underlying the SARS in payment of the exercise price and 1,544 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 7

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,162

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 6

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,143

F2 · kind: The reporting person received 4,920 shares of common stock upon the net exercise of the 19,672 SARS. The reporting person forfeited 12,102 shares of common stock underlying the SARS in payment of the exercise price and 2,650 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 5

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,793

F2 · kind: The reporting person received 4,920 shares of common stock upon the net exercise of the 19,672 SARS. The reporting person forfeited 12,102 shares of common stock underlying the SARS in payment of the exercise price and 2,650 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 9, 2017 of $72.81.

SEC source: 0001209191-17-031681 · doc4.xml · nonDerivative · entry 4

Fernandez Calero Miguel Angel · CIK 0001472194 · EVP, The Americas & WWD Ops

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,895

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.